XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (15,225) $ (10,544)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 446 601
Impairment charges 0 1,008
Share-based compensation 1,286 (9,199)
Change in fair value of warrants 24 (304)
Change in fair value of contingent consideration 0 1,125
Deferred income taxes 2 0
Non-cash operating lease expense 458 400
Other non-cash operating activities (119) (677)
Changes in assets and liabilities:    
Receivables, net (1,331) (1,497)
Inventories, net 133 (458)
Prepaid and other current assets (1,147) (1,786)
Trade payables and accrued liabilities 135 (3,084)
Contract liabilities 1,308 705
Change in contract loss provisions, net (824) (77)
Other non-current assets and liabilities 541 (345)
Net cash used in operating activities (14,313) (24,132)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (150) (527)
Purchases of available-for-sale securities 0 (44,520)
Maturities of available-for-sale securities 10,000 62,300
Net cash provided by investing activities 9,850 17,253
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of stock options 0 248
Payment related to taxes for net-share settlement of share-based compensation (17) 0
Net cash provided by (used in) financing activities (17) 248
Decrease in cash, cash equivalents and restricted cash (4,480) (6,631)
Cash, cash equivalents and restricted cash at the beginning of the period 64,215 47,874
Cash, cash equivalents and restricted cash at the end of the period 59,735 41,243
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 58,235 39,215
Short-term restricted cash 500 528
Long-term restricted cash 1,000 1,500
Total cash, cash equivalents and restricted cash 59,735 41,243
Non-cash investing and financing activities:    
Fair value of Project Warrants and Collaboration Warrants recognized in equity 51 76
Capital expenditures incurred but not yet paid $ 65 $ 56